This company has shut down. Day Zero Diagnostics is no longer operating — its last tracked round was a Venture - Series Unknown in 2023.
Explore the Startup GraveyardThe future of infectious disease diagnostics starts at Day Zero.
Day Zero Diagnostics has raised $16.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
Day Zero Diagnostics's investors include Sands Capital Ventures, MassChallenge, Panacea Venture, Triventures, CARB-X.
Day Zero Diagnostics is headquartered in Boston, United States.
The future of infectious disease diagnostics starts at Day Zero.
Day Zero Diagnostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Day Zero Diagnostics — Funding & Investors." VCBacked, September 20, 2023, https://www.vcbacked.co/company/day-zero-diagnostics. Accessed August 8, 2026.
VCBacked. (2023). Day Zero Diagnostics — Funding & Investors. Retrieved August 8, 2026, from https://www.vcbacked.co/company/day-zero-diagnostics
{{cite web |title=Day Zero Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/day-zero-diagnostics |website=VCBacked |access-date=August 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated